10x Genomics, Inc. (LON:0A88)
London
· Delayed Price · Currency is GBP · Price in USD 11.14
-0.70 (-5.93%)
At close: Feb 21, 2025
10x Genomics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Net Income | -182.63 | -255.1 | -166 | -58.22 | -542.73 | Upgrade
|
| Depreciation & Amortization | 43.71 | 43.62 | 33.01 | 28.25 | 19.02 | Upgrade
|
| Other Amortization | - | - | - | - | 0.02 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | 0.03 | Upgrade
|
| Asset Writedown & Restructuring Costs | 3.05 | 9.85 | - | - | 306 | Upgrade
|
| Loss (Gain) From Sale of Investments | 0 | 1.72 | - | - | - | Upgrade
|
| Stock-Based Compensation | 140.75 | 166.95 | 136.85 | 95.96 | 48.63 | Upgrade
|
| Other Operating Activities | 0.52 | 0.43 | 1.96 | 0.08 | 1.52 | Upgrade
|
| Change in Accounts Receivable | 26.95 | -10.61 | -18.95 | -34.04 | -17.85 | Upgrade
|
| Change in Inventory | -9.78 | 7.87 | -21.19 | -30.13 | -14.6 | Upgrade
|
| Change in Accounts Payable | -3.35 | -6.02 | 5.86 | 11.08 | -7.77 | Upgrade
|
| Change in Unearned Revenue | 11.21 | 10.93 | 3.35 | 1.54 | 2.02 | Upgrade
|
| Change in Other Net Operating Assets | -23.78 | 15.17 | -8.49 | -35.89 | -12.19 | Upgrade
|
| Operating Cash Flow | 6.66 | -15.2 | -33.61 | -21.37 | -217.9 | Upgrade
|
| Capital Expenditures | -12.39 | -48.6 | -131.66 | -101.28 | -36.67 | Upgrade
|
| Cash Acquisitions | - | - | -4 | -5.45 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -1 | -0.92 | - | - | -1.73 | Upgrade
|
| Investment in Securities | -19.24 | 183.02 | -215.23 | - | - | Upgrade
|
| Investing Cash Flow | -32.63 | 133.49 | -350.89 | -106.73 | -38.39 | Upgrade
|
| Long-Term Debt Repaid | - | -5.81 | -5.41 | -5.03 | -37.1 | Upgrade
|
| Total Debt Repaid | - | -5.81 | -5.41 | -5.03 | -37.1 | Upgrade
|
| Net Debt Issued (Repaid) | - | -5.81 | -5.41 | -5.03 | -37.1 | Upgrade
|
| Issuance of Common Stock | 10.91 | 19.48 | 21.23 | 40.33 | 506.01 | Upgrade
|
| Financing Cash Flow | 10.91 | 13.67 | 15.82 | 35.3 | 468.91 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.16 | -0.03 | -0.04 | 0.23 | -0.46 | Upgrade
|
| Net Cash Flow | -15.22 | 131.93 | -368.72 | -92.57 | 212.15 | Upgrade
|
| Free Cash Flow | -5.73 | -63.8 | -165.27 | -122.65 | -254.56 | Upgrade
|
| Free Cash Flow Margin | -0.94% | -10.31% | -32.00% | -25.01% | -85.18% | Upgrade
|
| Free Cash Flow Per Share | -0.05 | -0.54 | -1.45 | -1.11 | -2.52 | Upgrade
|
| Cash Interest Paid | - | 0.44 | 0.84 | 1.22 | 1.67 | Upgrade
|
| Cash Income Tax Paid | 5.64 | 4.93 | 3.93 | 8.66 | 0.28 | Upgrade
|
| Levered Free Cash Flow | 59.82 | 27.63 | -92.66 | -67.02 | -20.17 | Upgrade
|
| Unlevered Free Cash Flow | 59.83 | 27.65 | -92.36 | -66.48 | -19.14 | Upgrade
|
| Change in Net Working Capital | -9.05 | 8.56 | 28.21 | 56.35 | -4.93 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.